Recent Research


Genome Web


External link:* http://www.genomeweb.com/

Providing up-to-date news coverage on pharmacogenomics research

Author: GenomeWeb LLC

Related numbers to fix: 17 years

Personalized Medicine Coalition


External link:* http://www.personalizedmedicinecoalition.org/

The Personalized Medicine Coalition (PMC) is an independent, non-profit group that works to advance the understanding and adoption of personalized medicine for the ultimate benefit of patients.

Author: PMC

Related numbers to fix: 17 years

The Pharmacogenomics Knowledge Base


External link:* http://www.pharmgkb.org/index.jsp

A collection of knowledge about the impact of human genetic variations on drug response.

Author: Financially supported by grants from NIGMS, NHLBI, NHGRI, NIEHS, NCI, and NLM within the NIH, HHS.

Related numbers to fix: 17 years

Genomic Biomarkers


External link:* http://www.fda.gov/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm116034.htm

Table of Valid Genomic Biomarkers in the Context of Approved Drug Labels: Notes

Author: U.S. Food and Drug Administration - U.S. Department of Health and Human Services

Related numbers to fix: 17 years

Genomics at FDA


External link:* http://www.fda.gov/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm085339.htm

General information and related links to Genomics

Author: U.S. Food and Drug Administration - U.S. Department of Health and Human Services

Related numbers to fix: 17 years

The Pharmacogenetics Research Network


External link:* http://www.nigms.nih.gov/Initiatives/PGRN

The Pharmacogenetics Research Network (PGRN) is a nationwide collaboration of scientists studying the effect of genes on people's responses to a wide variety of medicines.

Author: National Institute of General Medical Sciences

Related numbers to fix: 17 years

Celera and Medco Enter Research Collaboration to Evaluate Effect of KIF6 Testing on Compliance with Statin Therapy in Patients with Cardiovascular Disease


External link:* http://medco.mediaroom.com/index.php?s=43&item=397

Celera Corporation and Medco Health Solutions, Inc. announced that they have entered into a research collaboration to evaluate whether testing for a gene variant called KIF6 increases patient adherence with statin therapy.

Author: Medco and Celera

Related numbers to fix: $475 Billion

Consumermedsafety.org


External link:* http://consumermedsafety.org/

ConsumerMedSafety.org is brought to you by the Institute for Safe Medication Practices (ISMP)—the nation's only nonprofit organization of pharmacists, nurses, and doctors devoted entirely to safe medication practices.

ISMP

Author: Institute for Safe Medicine Practices

Related numbers to fix: 2,000,000

Overweight and Obesity


External link:* http://www.cdc.gov/obesity/index.html

Information and statistics on overweight and obesity from the CDC

Author: Centers for Disease Control and Prevention (CDC)

Related numbers to fix: 30

A Pharmacy-Driven Fax Program Increases the Use of ACE Inhibitors and Angiotensin Receptor Blockers in Diabetes Patients


External link:* https://www.medcoresearch.com/docs/DOC-1221

The American Diabetes Association recommends the use of ace inhibitors (ACE-I) or angiotensin receptor blockers (ARB) in diabetes patients with certain clinical conditions, such as nephropathy or hypertension. However, these agents are not frequently prescribed to many patients for whom treatment is indicated.

Author: Rob Konkus, RPh, Jennifer Utterdyke, RPh, et al.

Related numbers to fix: $116 Billion, 23,600,000
divider
* By selecting an external link, you will be leaving the Making Medicine Smarter website and linking to another website which may be governed by a separate and different Terms of Use and Privacy Policy.

Medco is a registered trademark and Medco Making Medicine Smarter is a trademark of Medco Health Solutions, Inc.
Copyright 2009 Medco Health Solutions, Inc. All Rights Reserved.